These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4999633)

  • 21. [Action in vitro of antibacillar drug combinations on pluriresistant strains of tubercle bacilli].
    Kreis B; Fournaud S
    Rev Tuberc Pneumol (Paris); 1966 Apr; 30(4):445-60. PubMed ID: 4958256
    [No Abstract]   [Full Text] [Related]  

  • 22. [Secondary resistance of tubercle bacilli to antibiotics].
    Kurdziel Z
    Przegl Lek; 1966; 22(10):645-8. PubMed ID: 4960191
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative study of biweekly streptomycin and isoniazid with daily P.A.S. and isoniazid regimens in the treatment of pulmonary tuberculosis.
    Mathur JB; Bahadur P; Agnihotri CB
    J Indian Med Assoc; 1967 Aug; 49(4):162-5. PubMed ID: 5594009
    [No Abstract]   [Full Text] [Related]  

  • 24. The treatment of renal tuberculosis.
    Beck AD
    Aust N Z J Surg; 1969 May; 38(4):342-6. PubMed ID: 4977937
    [No Abstract]   [Full Text] [Related]  

  • 25. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI; Grishina TA; Karpenko OL; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (4):37-40. PubMed ID: 7567869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effects of antituberculosis chemotherapy in vitro under various conditions inadequate for the growth of tubercle bacilli. I. Incubating temperature and chemotherapeutic effect].
    Maekawa N; Nakanishi M; Kawai M; Ikeda N; Nakai H
    Kekkaku; 1971 Jul; 46(7):235-7. PubMed ID: 5000367
    [No Abstract]   [Full Text] [Related]  

  • 27. Trends in drug resistance of mycobacterium tuberculosis.
    Hejny J
    Indian J Chest Dis Allied Sci; 1982; 24(2-3):190-4. PubMed ID: 6819998
    [No Abstract]   [Full Text] [Related]  

  • 28. Incidence of resistance to primary and secondary antituberculosis drugs in isolates of M. tuberculosis from cases of pulmonary tuberculosis.
    Kothadia SN; Sengupta SR
    Indian J Chest Dis Allied Sci; 1984; 26(3):163-6. PubMed ID: 6443608
    [No Abstract]   [Full Text] [Related]  

  • 29. The syndrome of open cavity healing.
    Zierski M
    Scand J Respir Dis Suppl; 1968; 65():151-6. PubMed ID: 4978459
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):29-44. PubMed ID: 5300097
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of DNA-tropic substances used jointly with tuberculostatic preparations on the development of drug resistance in Mycobacterium tuberculosis].
    Il'ina TB; Vishnevskiĭ BI
    Probl Tuberk; 1980 May; (5):67-70. PubMed ID: 6770368
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies on the effects of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). II. Studies in vivo].
    Ota Y
    Kekkaku; 1971 Dec; 46(12):493-500. PubMed ID: 5004603
    [No Abstract]   [Full Text] [Related]  

  • 33. Problems of treatment of drug resistance in the developing countries.
    Fox W
    Tubercle; 1969 Mar; 50():Suppl:55-65. PubMed ID: 5402546
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follow-up of positive cases of pulmonary tuberculosis diagnosed in 1957.
    Christensen O
    Scand J Respir Dis Suppl; 1968; 63():9-28. PubMed ID: 4972112
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies on the problems of resistance to antituberculous drugs. II--2. Clinically significant critical concentration of streptomycin, isoniazid, kanamycin and ethambutol].
    Baba H
    Kekkaku; 1994 Jun; 69(6):397-407. PubMed ID: 8041058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Resistance to antitubercular drugs in Chile].
    Valenzuela MT; Scheel G; Ponce J; Lepe R; Velasco M; Valenzuela P
    Rev Med Chil; 1984 Jan; 112(1):76-80. PubMed ID: 6429808
    [No Abstract]   [Full Text] [Related]  

  • 38. [A comparative study of the relationship between the growth rate of tubercle bacilli and the concentration of antituberculous agents (author's transl)].
    Tsukamura M; Mizuno S
    Kekkaku; 1980 Aug; 55(8):365-70. PubMed ID: 6775122
    [No Abstract]   [Full Text] [Related]  

  • 39. [Possibilities of advances in the determination of drug resistance of tubercle bacilli].
    Buraczewska M
    Gruzlica; 1971 Aug; 39(8):729-37. PubMed ID: 4999630
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies of the geographical spread of drug-resistant tubercle bacilli in a city.
    Tinne JE
    J Med Microbiol; 1971 May; 4(2):P3. PubMed ID: 4998858
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.